About Spero Oncology
Spero Oncology is a company based in Bellshill (United Kingdom) founded in 2014 was acquired by Veristat in May 2016. Spero Oncology operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.
- Headquarter Bellshill, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Spero Oncology
Detailed funding history for Spero Oncology
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Spero Oncology
Spero Oncology has secured backing from 1 investor. Prominent investors backing the company include Veristat.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical trials and regulatory submissions are supported as a CRO.
|
Locked | Locked | Locked |
Investor details for Spero Oncology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spero Oncology
Investment portfolio details for Spero Oncology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spero Oncology
Detailed financials for Spero Oncology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spero Oncology Comparisons
Peer comparison for Spero Oncology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spero Oncology
Spero Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| Locked | Locked | Locked |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| Locked | Locked | Locked |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| Locked | Locked | Locked |
CRO offering clinical development services for oncology drugs
|
|
| Locked | Locked | Locked |
Preclinical and clinical oncology drug development services are provided.
|
Detailed competitors of Spero Oncology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spero Oncology
Complete news archive for Spero Oncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spero Oncology
Spero Oncology was founded in 2014.
Spero Oncology is headquartered in Bellshill, United Kingdom. It is registered at Bellshill, Scotland, United Kingdom.
Spero Oncology was established in 2014 in Bellshill, United Kingdom, as a contract research organization focused on the oncology sector. Clinical operations support is delivered for oncology trials, encompassing feasibility studies, legal representation in the European Union, clinical monitoring, project management, protocol writing, and regulatory strategy. Services are extended primarily across Europe, Australia, and New Zealand. The organization was acquired by U.S.-based CRO Veristat for an undisclosed amount.
Spero Oncology has 1 investor. Key investors include Veristat.